We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Can we make drugs that not only break/inhibit interactions between a protein and a ligand, but rather bestow new functionality? Nicolas Thomä explores molecular glue drugs, and their potential to make much needed medicines that were previously out of reach.
